Amneal Pharmaceuticals, Inc. (AMRX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
AMRX currently has 316M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 2.43% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 316.0M shares outstanding |
320M | 0 |
| Nov 06, 2025 |
10-Q filing | 314.2M shares outstanding |
310M | 0 |
| Aug 07, 2025 |
10-Q filing | 313.7M shares outstanding |
310M | 0 |
| May 07, 2025 |
10-Q filing | 311.1M shares outstanding |
310M | 0 |
| Feb 28, 2025 |
10-K filing | 309.0M shares outstanding |
310M | 0 |
| Nov 12, 2024 |
10-Q filing | 309.6M shares outstanding |
310M | 0 |
| Aug 09, 2024 |
10-Q filing | 309.1M shares outstanding |
310M | 0 |
| May 08, 2024 |
10-Q filing | 307.3M shares outstanding |
310M | 0 |
| Mar 14, 2024 |
10-K filing | 307.0M shares outstanding |
310M | 0 |
| Nov 09, 2023 |
10-Q filing | 306.5M shares outstanding |
310M | 0 |
| Nov 08, 2023 |
POS AM filing: This POS AM filing relates to the issuance and sale by Amneal Pharmaceuticals, Inc. of Class A common stock, preferred stock, and debt securities for an aggregate initial offering price not to exceed $1,250,000,000. |
150M | 0 |
| Aug 08, 2023 |
10-Q filing | 153.7M shares outstanding |
150M | 0 |
| May 09, 2023 |
10-Q filing | 152.1M shares outstanding |
150M | 0 |
| Mar 06, 2023 |
POS AM filing: The filing is a POS AM (Post-Effective Amendment) relating to the potential offering and sale of up to 171,227,752 shares of Class A common stock by selling stockholders. |
150M | 0 |
| Mar 06, 2023 |
POS AM filing: Amneal Pharmaceuticals, Inc. may offer and sell Class A common stock, preferred stock, and debt securities from time to time in one or more offerings, up to a total amount of $1,250,000,000. |
150M | 0 |
| Mar 03, 2023 |
10-K filing | 150.9M shares outstanding |
150M | 0 |
| Nov 07, 2022 |
10-Q filing | 151.4M shares outstanding |
150M | 0 |
| Aug 08, 2022 |
10-Q filing | 151.0M shares outstanding |
150M | 0 |
| May 06, 2022 |
10-Q filing | 149.9M shares outstanding |
150M | 0 |
| Mar 01, 2022 |
10-K filing | 148.9M shares outstanding |
150M | 0 |
| Nov 08, 2021 |
10-Q filing | 149.3M shares outstanding |
150M | 0 |
| Aug 09, 2021 |
10-Q filing | 149.0M shares outstanding |
150M | 0 |
| May 07, 2021 |
10-Q filing | 148.0M shares outstanding |
150M | 0 |
| Mar 01, 2021 |
10-K filing | 147.4M shares outstanding |
150M | 0 |
| Nov 06, 2020 |
10-Q filing | 147.6M shares outstanding |
150M | 0 |
| Aug 06, 2020 |
10-Q filing | 147.4M shares outstanding |
150M | 0 |
| May 11, 2020 |
10-Q filing | 147.2M shares outstanding |
150M | 0 |
| Mar 02, 2020 |
10-K filing | 147.1M shares outstanding |
150M | 0 |